A case report of a patient with a renal carcinoma and metachronously affected bilateral adrenal glands and her contralatral kidney over a period of 16 years

Czech version

Authors: Petr Klézl ¹; Kateřina Licková ²; Jindřich Šonský ¹; Aleš Fiala ¹; Petr Nencka ¹; Robert Grill ¹
Authors‘ workplace: Urologická klinika FN Královské Vinohrady a 3. LF UK Praha ¹; Onkologická klinika FN Královské Vinohrady a 3. LF UK Praha ²
Published in: Ces Urol 2018; 22(4): 285-290
Category: Case report

Overview

We present a case report of a 64 years old female patient with renal carcinoma and metachronic metastases to the contralateral kidney, subcutaneous tissue and both adrenals glands during a course of 16 years after primary nephrectomy. Renal carcinoma metastases occur after several years most often in the area of the lungs, lymph nodes and the liver. At the time of diagnosis, approximately 25 % of patients have a generalized disease. The occurrence of metastases is dependent on the histological type, grade and size of the tumor. Bilateral metastases in the adrenal gland and the contralateral kidney are a challenge in the diagnosis and treatment of the disease because there are standard defined procedures for the treatment of these patients in the literature. We repeatedly used surgery because it seemed the most optimal solution in view of the development of the disease and the condition of the patient.

KEY WORDS

Renal carcinoma, metachronous metastases, nephrectomy.

Sources

1. Novák J, Stolz J, Babjuk M, Hanuš T, Jarolím T. Léčba generalizovaného karcinomu ledviny. Ces Urol 2001; 3: 40–43.

2. Patard JJ, Leray E, Rioux‑Leclercq N, et al. Prognostic value of histological subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005; 23(12): 2763–2771.

3. Sobotka R, Hanuš T. Nádory ledvin. Postgraduální medicína 2011: 1.

4. Kawaciuk I. Prognóza karcinomu ledviny. Praha: Galén 2005.

5. Leibovich BC, Blute ML, Cheville JC, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003; 97(7): 1663–1671.

6. Mesurolle B, Mignon F, Travagli JP, Meingan P, Vanel D. Late presentation of solitay contralateral adrenal metastasis of renal cell carcinoma. Eur Radiol 1997; 7: 557–558.

7. Kuczyk M, Münch T, Machtens S, et al. The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience. BJU Int. 2002; 89: 517–522.

8. Kobayashi T, Nakamura E, Yamamoto S, et al. Low incidence of ipsilateral adrenal involvement and recurrences in patients with renal cell carcinoma undergoing radical nephrectomy: a retrospective analysis of 393 patients. Urology 2003; 62: 40–45.

9. Alt AL, Boorjian SA, Lohse CM, et al. Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 2011; 117: 2873–2882.

10. Yu CC, Huang JK, Tzeng WS, et al. Simultaneous bilateral adrenal metastases from renal cell carcinoma. Surgical implications and review of the literature. Eur Urol. 1992; 22: 335–338.

11. Karam JA, Wood CG. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy. Hematol Oncol Clin North Am. 2011; 25: 753–764.

12. Kessler OJ, Mukamel E, Weinstein R, et al. Metachronous renal cell carcinoma metastasis to the contralateral adrenal gland. Urology 1998; 51: 539–543.

13. Becker F, Siemer S, Tzavaras A, Suttmann H, Stoeckle M. Long‑term survival in bilateral renal cell carcinoma: a retrospective single‑institutional analysis of 101 patients after surgical treatment. Urology 2008; 72: 349–353.

14. Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Eur. Urol. 2008; 54: 855–865.